Today, I’ll be talking about the U.S.dollar. I think this is very important, so please listen up.
Eli Lilly and Company
Instead of Chasing Every New Vaccine "Breakthrough," Trade the Whole Sector
Start the conversation
You must be logged in to post a comment.
Not every biotech company is doing well in the search for an effective COVID-19 vaccine or treatment.
And the latest firm to struggle is Eli Lilly, whose antibody clinical trial was paused due to failure to show any real results.
So today, Andrew's going to show you a much more profitable move to make instead of chasing every vaccine "breakthrough" news…
What to Do When the Market Sells Off Like This
Start the conversation
You must be logged in to post a comment.
Driven by headlines, stocks were in a triple-digit freefall at midday Monday.
But the really important thing to understand is how and why the market leaders failed because it points to what we should be doing.
Here’s Shah to explain what’s happening and what you can do about it….
The Irish Knight Who “Invented” Gatorade Pioneered Medical Cannabis – and Led Us to This $7 Cannabis Stock
Start the conversation
You must be logged in to post a comment.
Today, our Don Yocham will be telling you a real “Knight’s Tale” about William O’Shaughnessy, who pioneered medical cannabis and led us to this $7 cannabis stock.
That’s right, this is the kind of “Knight’s Tale” that can make you rich….
Is This the Start of a Stock Market Crash?
Start the conversation
You must be logged in to post a comment.
Volatility returned to the markets in the last week as the VIX spiked 38.5% and the S&P 500 experienced a 7% decline.
With the economy still struggling, investors are wondering if this is the start of another stock market crash.
But it could also be just a bit of “fat trimming” in a longer-term bull market poised to go higher.
Here's everything you need to know now...
Dow Jones Pops 200 Points Despite Growing Unemployment Numbers
Start the conversation
You must be logged in to post a comment.
The Dow Jones is flat today after the Department of Labor announced 4.4 million more unemployed this week.
The coronavirus pandemic continues to hurt oil prices and create new geopolitical tensions in the United States.
We cover everything hitting the Dow Jones today.
The Answer to Big Pharma's Biggest Problem Could Double Your Money in Just Three Years
Start the conversation
You must be logged in to post a comment.
You could forgive drug and biotech executives for having a bad case of target fixation.
After all, they do work in a field that is filled with time-consuming and expensive headaches.
Consider that the Biotechnology Innovation Organization (BIO), the world's largest biotech trade organization, looked at 7,400 drug programs by 1,103 companies. They were investigating drug-approval rates.
The news was not good -just 9.6% of drugs scientists discover ever get approved for sale. That's a one-in-ten shot.
With such daunting data, it's no wonder that, even in a field already worth $1.2 trillion in global sales, industry leaders are on the lookout for ways to lower the cost of discovery and shorten time to market.
And with that goal in mind, I've uncovered a high-octane, large-cap firm that has become an essential ingredient in the drug sector's success.
It's a cloud-based leader in pharmaceutical efficiency that has a history of crushing the market by no small measure.
And it's been doubling its earnings, on average, every 18 months...
The 2 Best Healthcare Stocks to Buy in July 2018
Start the conversation
You must be logged in to post a comment.
Money Morning Quantitative Specialist Chris Johnson has two top picks for the best healthcare stocks to buy in July.
Chris's proprietary "Best in Breed" (BiB) system finds both aggressive companies and discovers undervalued sectors poised for massive gains.
And his BiB system has uncovered breakout potential for the healthcare industry...
Two Breakout Healthcare Stocks Set for Double-Digit Gains
Start the conversation
You must be logged in to post a comment.
As promised, our Chris Johnson is back with two breakout healthcare stocks that are set for double-digit gains.
In fact, you can get plenty of upside opportunity with this latest Best in Breed play...
Dow Jones Today Rallies After Donald Trump's State of the Union Address
Start the conversation
You must be logged in to post a comment.
The Dow Jones today rebounds from a brutal two-day selloff fueled by concerns about rising bond yields.
Dow futures are up 213 points in premarket hours as investors weighed on President Donald Trump's first State of the Union Address. Automatic Data Processing reported that private payrolls increased by 234,000 in January, topping average expectations of 185,000.
Start the conversation